Title:
抗精神病薬と組み合わせたカンナビノイドの使用
Document Type and Number:
Japanese Patent JP5409650
Kind Code:
B2
Abstract:
The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin acid (THCVA); cannabichromene (CBC); cannabichromenic acid (CBCA); cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.
More Like This:
| WO/2008/143137 | ANTIVIRAL AGENT |
| WO/2020/124220 | CANNABIS COMPOSITIONS AND METHODS |
| JP5820115 | Composition for oral ingestion |
Inventors:
Tetsuro Kikuchi
Kenji Maeda
Guy Jeffrey
Robson phillip
Stott Colin
Kenji Maeda
Guy Jeffrey
Robson phillip
Stott Colin
Application Number:
JP2010541094A
Publication Date:
February 05, 2014
Filing Date:
December 17, 2008
Export Citation:
Assignee:
GW PHARMA LIMITED
International Classes:
A61K31/05; A61K31/352; A61K31/497; A61P25/18; A61P25/22; A61P25/24; A61P43/00
Domestic Patent References:
| JP2007503460A |
Foreign References:
| WO2006054057A1 | ||||
| WO2007138322A1 | ||||
| WO2007144628A1 | ||||
| WO2007148094A1 |
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office